statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$1000 Invested In Accenture 15 Years Ago Would Be Worth This Much Today

Accenture Pioneers Custom Llama LLM Models with NVIDIA AI Foundry

Accenture (NYSE:ACN) today announced the launch of the Accenture AI Refinery framework, built on NVIDIA AI Foundry, to enable clients to build custom LLM models with the Llama 3.1 collection of...

A Science-Backed Approach to Change Can Double the Success of Transformation Efforts, New Accenture Report Finds

According to a new report from Accenture (NYSE:ACN), the vast majority of global organizations (96%) are planning to invest more than 5% of their total revenues in change initiatives over the next...

How Is The Market Feeling About Accenture?

Accenture to Acquire Camelot Management Consultants to Expand SAP and Supply Chain Capabilities

Accenture (NYSE: ACN) has agreed to acquire Camelot Management Consultants, an international SAP-focused management and technology consulting firm from Germany, with specific strengths in supply...

Wall Street analysts on Friday are seeing some exciting opportunities in the tech and biotechnology sectors, and doled out some positive notes. Let’s find out if retail investors are nodding to these cues.Morgan Stanley Upgrades Arm (ARM) to Overweight:&nbsp;Analysts at Morgan Stanley are bullish on Arm Holdings PLC,citing the company's potential for growth in the emerging edge artificial intelligence (AI) space. They upgraded the stock from Equal Weight to Overweight and raised the price target to $190, up from $107.&nbsp;Retail investors on Stocktwits also seem to agree, with bullish sentiment (66/100) following the upgrade. One popular <a href="https://stocktwits.com/Rocket_5227/message/580033550">post</a> even pointed out that the stock is "filling the first gap up at around $175" after the price target increase.<figure class="image"><img style="aspect-ratio:1324/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ARM_Stocktwits_sentiment_Jul_19_484bd7e946.png" alt="ARM Stocktwits sentiment Jul 19.png" width="1324" height="314"><figcaption>ARM Stocktwits sentiment Jul 19</figcaption></figure>UBS Upgrades Accenture (ACN) to Buy:&nbsp;UBS upgraded Accenture Plc to Buy from Neutral, citing the company's opportunity for multiple expansion as the market anticipates accelerating revenue growth in AI.&nbsp;However, Stocktwits sentiment is more neutral (53/100) on ACN, possibly due to some hesitation over the company's recent acquisition spree — like Logic (a retail technology services firm) and True North Solutions (an industrial engineering solutions provider) — and recent underwhelming financial performance.The company missed earnings estimates in its last quarter and its stock is down 4.60% year-to-date (YTD). It will be interesting to see if Accenture can meet analyst expectations and turn around investor sentiment.<figure class="image"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ACN_Stocktwits_sentiment_Jul_19_0702197af4.png" alt="ACN Stocktwits sentiment Jul 19.png" width="1318" height="318"><figcaption>ACN Stocktwits sentiment Jul 19</figcaption></figure>JPMorgan Upgrades AnaptysBio (ANAB) to Overweight:&nbsp;JPMorgan upgraded AnaptysBio Inc to Overweight, with a price target of $69, up from $29. This significant upgrade reflects the potential of the company's lead candidate, rosnilimab.&nbsp;Rosnilimab is designed to treat rheumatoid arthritis and ulcerative colitis, and it has shown promise in clinical trials, according to Investing.com. Analysts are also particularly excited about the upcoming Phase 2b results for rosnilimab in rheumatoid arthritis, which are expected by mid-2025.Retail investors on Stocktwits are also extremely bullish on ANAB (81/100), likely due to the recent upgrade and the potential for upside. Notably, JPMorgan's upgrade suggests a potential 103% upside from the current stock price.<figure class="image"><img style="aspect-ratio:1320/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ANAB_Stocktwits_sentiment_Jul_19_ff3e590ce1.png" alt="ANAB Stocktwits sentiment Jul 19.png" width="1320" height="320"><figcaption>ANAB Stocktwits sentiment Jul 19</figcaption></figure>&nbsp;&nbsp;

Wall Street Bets Big On ARM, ACN, ANAB: Do Retail Investors Concur?

Analysts have issued upgrades for Arm (ARM), Accenture (ACN), and AnaptysBio (ANAB). Here’s how the Stocktwits community reacted.

Equity

Deep Dive Into Accenture Stock: Analyst Perspectives (20 Ratings)

Latest Ratings for ACN
 DateFirmActionFromTo Mar 2022Goldman SachsMaintainsNeutral Jan 2022Goldman SachsInitiates Coverage OnNeutral Dec 2021BarclaysMaintainsOverweight
 View More Analyst...

New Research from Accenture Finds that Digital Core Investments Accelerate Reinvention and Innovation, Delivering up to 60% Higher Revenue Growth Rates and 40% Boost in Profit

New research from Accenture (NYSE: ACN) finds that organizations with an advanced digital core, investments in strategic innovation and a balanced approach to their technical debt achieved 60% higher...

Trade Tracker: Amy Raskin trims Costco and sells Accenture

Trade Tracker: Amy Raskin trims Costco and sells Accenture...

Accenture to Enhance Retail Technology Transformation Capabilities with the Acquisition of Logic

Accenture (NYSE: ACN) has entered into an agreement to acquire Logic, a retail technology services firm that works with retailers to drive customer loyalty, boost revenue and increase agility through...

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The company combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. Accenture operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1951 and is headquartered in Dublin, Ireland.

Volume	2.44M
52-Wk High	$387.51
52-Wk Low	$278.69

ACN Accenture plc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community